This review discusses our studies on molecular mechanisms of acrylamide neurotoxicity by using the rat pheochromocytoma (PC12) cell line. The results showed that: a) acrylamide altered the gross morphology of PC12 cells; b) acrylamide induced neurofilament accumulation in PC12 cells; c) the effects of acrylamide on PC12 cells are consistent with its neurotoxicity in vivo; d) acrylamide stimulated neurofilament protein synthesis in PC12 cells; e) acrylamide did not act via nerve growth factor (NGF) receptor gp140trk to regulate neurofilament synthesis in PC12 cells; f) dexamethasone antagonised NGF and/or acrylamide-induced neurofilament protein synthesis and expression; and g) acrylamide differentially regulated the mRNA levels of three neurofilament subunit genes in PC12 cells. These molecular studies provide the first evidence that: a) there are distinctive and convergent signalling pathways for NGF-regulated and acrylamide-regulated neurofilament expression; b) acrylamide may differentially regulate the expression of each subunit, resulting in aberrant accumulation of neurofilament proteins; and c) there is a dexamethasone-sensitive signalling step common to NGF and acrylamide. These results could partially explain the mechanisms of neurofilament accumulation in distal axonal swellings, a pathognomonic feature of acrylamide neurotoxicity.
DearfieldK.L., AbernathyC.O., OttleyM.S., BrantnerJ.H., and HayesP.E. (1988). Aciylamide: its metabolism, developmental and reproductive effects, genotoxicity, and carcinogenicity.Mutation Research195, 45–77.
2.
HamblinD.O. (1956). The toxicity of acrylamide: a preliminary report. In Hommage au Doyen Rene Fabre (eds.), pp. 159. Paris: Sedes.
3.
EdwardsP.M., Sporel-OzakatE., and GispenW.H. (1991). Neurotoxic acrylamide and neurotrophic melanocortin peptides: can contrasting actions provide clues about modes of action?Neuropathology and Applied Neurobiology17, 91–104.
4.
ShawG. (1991). Neurofilament proteins. In The Neuronal Cytoskeleton (ed. BurgoyneR.D.), pp. 185–214. New York: Wiley-Liss.
5.
CoteF., CollardJ.F., and JulienJ.P. (1993). Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis.Cell73, 35–46.
6.
XuZ., CorkL.C., GriffinJ.W., and ClevelandD.W. (1993). Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease.Cell73, 23–33.
7.
BradyS.T. (1993). Motor neurons and neurofilaments in sickness and in health.Cell73, 1–3.
8.
LeeM.K., and ClevelandD.W. (1994). Neurofilament function and dysfunction: involvement in axonal growth and neuronal disease.Current Opinions in Cell Biology6, 34–40.
9.
LindenbaumM.H., CarbonettoS., and MushynskiW.E. (1987). Nerve growth factor enhances the synthesis, phosphorylation, and metabolic stability of neurofilament proteins in PC12 cells.Journal of Biological Chemistry262, 605–610.
10.
LindenbaumM.H., CarbonettoS., GrosveldF., FlavellD., and MushynskiW.E. (1988). Transcriptional and post-transcriptional effects of nerve growth factor on expression of the three neurofilament subunits in PC12 cells.Journal of Biological Chemistry263, 5662–5667.
11.
FujitaK., LazaroviciP., and GuroffG. (1989). Regulation of the differentiation of PC12 pheochromocytoma cells.Environmental Health Perspectives80, 127–142.
12.
HalegouaS., ArmstrongR.C., and KremerN.E. (1991). Dissecting the mode of action of a neuronal growth factor.Current Topics in Microbiology and Immunology165, 119–170.
13.
GreeneL.A., and TischlerA.S. (1982). PC12 pheochromocytoma cultures in neurobiological research.Advances in Cell Neurobiology3, 327–341.
14.
EdwardsP.M. (1975). Neurotoxicity of acrylamide and its analogues and effects of these analogues and other agents on acrylamide neuropathy.British Journal of Industrial Medicine32, 31–38.
15.
HashimotoK., SakamotoJ., and TaniiH. (1981). Neurotoxicity of acrylamide and related compounds and their effects on male gonads in mice.Archives of Toxicology47, 179–189.
16.
SegaG.A., GenerosoE.E., and BrimerP.A. (1990). Acrylamide exposure induces a delayed unscheduled DNA synthesis in germ cells of male mice that is correlated with the temporal pattern of adduct formation in testis DNA.Environmental and Molecular Mutagenesis16, 137–142.
17.
CallemanC.J., BergmarkE., and CostaL.G. (1990). Acrylamide is metabolised to glycidamide in the rat: evidence from haemoglobin adduct formation.Chemical Research in Toxicology3, 406–412.
18.
BergmarkE., CallemanC.J., and CostaL.G. (1991). Formation of haemoglobin adducts of acrylamide and its epoxide metabolite glycidamide in the rat.Toxicology and Applied Pharmacology111, 352–363.
19.
BergmarkE., CallemanC.J., HeF., and CostaL.G. (1993). Determination of haemoglobin adducts in humans occupationally exposed to acrylamide.Toxicology and Applied Pharmacology120, 45–54.
20.
SumnerS.C., MacNeelaJ.P., and FennellT.R. (1992). Characterisation and quantitation of urinary metabolites of [1,2,3-13C]acrylamide in rats and mice using 13C nuclear magnetic resonance spectroscopy.Chemical Research in Toxicology5, 81–89.
21.
Abou-DoniaM.B., IbrahamS.M., CorcoranJ.J., LackL., FriedmanM.A., and LapadulaD.M. (1993). Neurotoxicity of glycidamide, an acrylamide metabolite, following intraperitoneal injections in rats.Journal of Toxicology and Environmental Health39, 447–464.
22.
HayashiM., TaniiH., HoriguchiM, & HashimotoK. (1989). Cytotoxic effects of acrylamide and its related compounds assessed by protein content, LDH activity and cumulative glucose consumption of neuron-rich cultures in a chemically defined medium.Archives of Toxicology63, 308–313.
23.
BratD.J., and BrimijoinS. (1993). Acrylamide and glycidamide impair neurite outgrowth in differentiating N1E.115 neuroblastoma without disturbing rapid bidirectional transport of organelles observed by video microscopy.Journal of Neurochemistry60, 2145–2152.
24.
ShaferT.J., and AtchisonW.D. (1991). Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neurotoxicological studies.Neurotoxicology12, 473–492.
25.
BorowitzJ.L., KanthasamyA.G., MitchellP.J., and IsomG.E. (1993). Use of PC12 cells as a neurotoxicological screen: characterisation of anti-cyanide compounds.Fundamental and Applied Toxicology20, 133–140.
26.
KnuselB., and HeftiF. (1992). K-252 compounds: modulators of neurotrophin signal transduction.Journal of Neurochemistry59, 1987–1996.
27.
HashimotoS. (1988). K-252a, a potent protein kinase inhibitor, blocks nerve growth factor-induced neurite outgrowth and changes in the phosphorylation of proteins in PC12h cells.Journal of Cell Biology107, 1531–1539.
28.
KoizumiS., ContrerasM.L., MatsudaY., HamaT., LazaroviciP., and GuroffG. (1988). K-252a: a specific inhibitor of the action of nerve growth factor on PC12 cells.Journal of Neuroscience8, 715–721.
29.
YamamotoK.R. (1985). Steroid receptor regulated transcription of specific genes and gene networks.Annual Review of Genetics19, 209–252.
30.
ForemanP.J., TaglialatelaG., JacksonG.R., & Perez-PoloJ.R. (1992). Dexamethasone blocks nerve growth factor induction of nerve growth factor receptor mRNA in PC12 cells.Journal of Neuroscience Research31, 52–57.
31.
Perrone-BizzozeroN.I., CansinoV.V., and KohnD.T. (1993). Post-transcriptional regulation of GAP-43 gene expression in PC12 cells through protein kinase C-dependent stabilisation of the mRNA.Journal of Cell Biology120, 1263–1270.
32.
CostelloB., MeymandiA., and FreemanJ.A. (1990). Factors influencing GAP-43 gene expression in PC12 pheochromocytoma cells.Journal of Neuroscience10, 1398–1406.
33.
FederoffH.J., GrabczykE., and FishmanM.C. (1988). Dual regulation of GAP-43 gene expression by nerve growth factor and glucocorticoids.Journal of Biological Chemistry263, 19290–19295.
34.
SteinR., MoriN., MatthewsK., LoL.C., and AndersonD.J. (1988). The NGF-inducible SCG10 mRNA encodes a novel membrane-bound protein present in growth cones and abundant in developing neurons.Neuron1, 463–476.
35.
ToccoM.D., FujitaK., and GuroffG. (1992). Effect of dexamethasone on the nerve growth factor-induced increase in the NILE glycoprotein in PC12 cells.Journal of Neuroscience Research31, 28–32.
36.
ZhangZ., TaroneG., and TurnerD.C. (1993). Expression of integrin α1β1 is regulated by nerve growth factor and dexamethasone in PC12 cells: functional consequences for adhesion and neurite outgrowth.Journal of Biological Chemistry268, 5557–5565.
37.
IfuneC.K., and SteinbachJ.H. (1990). Regulation of sodium currents and acetylcholine responses in PC12 cells.Brain Research506, 243–248.
38.
KimK.T., ParkD.H., and JohT.H. (1993). Parallel up-regulation of catecholamine biosynthetic enzymes by dexamethasone in PC12 cells.Journal of Neurochemistry60, 946–951.
39.
BowyerJ.F., NakanishiA., HouchiH., DreyerE., SterlingC., MasseranoJ.S., TankA.W., and WeinerN. (1992). Phosphorylation and activation of tyrosine hydroxylase in PC18 cells: a cell line derived from rat pheochromocytoma PC12 cells.Brain Research591, 261–270.
40.
McMahonA., and SabbanE.L. (1992). Regulation of expression of dopamine beta-hydroxylase in PC12 cells by glucocorticoids and cyclic AMP analogues.Journal of Neurochemistry59, 2040–2047.
